In 2023, Canada's diuretic medicine sales demonstrated a notable year-on-year growth of 7.64%, leading among the countries analyzed, with a significant market value of $288.7 million. South Korea followed with a 9.13% increase. The Czech Republic saw a modest growth of 1.35%. Meanwhile, Portugal and Luxembourg witnessed declines at -4.27% and -5.22%, respectively. Estonia's sales remained stable, while other countries like Finland, Chile, Norway, and Iceland experienced minor fluctuations. The five-year CAGR across these markets highlights varying dynamics, with Canada and South Korea positioning strongly for future growth.
Future trends in the global diuretic medicine market to watch include advances in pharmaceutical technology, changing healthcare regulations, and demographic shifts impacting demand across regions. Focus on these areas will be essential for stakeholders looking to capitalize on emerging opportunities in the field.
Top countries in Diuretic Medicine Sales by Country
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Canada | 288.7 | 2023 | +2.78% | +7.64% | View data |
| 2 | 2 South Korea | 32.2 | 2023 | +8.42% | +9.13% | View data |
| 3 | 3 Czech Republic | 26.3 | 2023 | +1.94% | +1.35% | View data |
| 4 | 4 Portugal | 20.5 | 2023 | -7.24% | -4.27% | View data |
| 5 | 5 Norway | 15.3 | 2023 | +2% | -1.01% | View data |
| 6 | 6 Chile | 11.2 | 2023 | +2.75% | +2.71% | View data |
| 7 | 7 Finland | 10.9 | 2023 | 0% | +2.36% | View data |
| 8 | 8 Estonia | 2.5 | 2023 | +4.17% | 0% | View data |
| 9 | 9 Iceland | 1.8 | 2023 | 0% | -1.08% | View data |
| 10 | 10 Luxembourg | 1.3 | 2023 | 0% | -5.22% | View data |
